The drug MDMA (3,4-methylenedioxy-N-methylamphetamin) is more commonly known by what name?
3,4-Methylenedioxy-N-hydroxy-N-methylamphetamine Act. 3,4-Methylenedioxy-N-hydroxy-N-methylamphetamine 3,4-Methylenedioxy-"N"-hydroxy-"N"-methylamphetamine (MDHMA; FLEA) is an entactogen, psychedelic, and stimulant of the phenethylamine and amphetamine chemical classes. It is the "N"-hydroxy homologue of MDMA ("Ecstasy"), and the "N"-methyl homologue of MDOH. MDHMA was first synthesized and assayed by Alexander Shulgin. In his book "PiHKAL" ("Phenethylamines i Have Known And Loved"), Shulgin listed the dosage range as 100–160 mg, and the duration as approximately 4–8 hours. He describes MDHMA as causing entactogenic and open MDMA-like effects, easing communication, and increasing appreciation of the senses. This substance is a Class A drug in the Drugs controlled by the UK Misuse of
3,4-Methylenedioxy-N-ethylamphetamine his book PiHKAL. In the United States, MDEA was introduced recreationally in 1985 as a legal substitute to the newly banned MDMA. MDEA was made a Schedule 1 substance in the United States on August 13, 1987 under the Federal Analog Act. 3,4-Methylenedioxy-N-ethylamphetamine 3,4-Methylenedioxy-"N"-ethylamphetamine ("MDEA"; also called "MDE" and colloquially, "Eve") is an empathogenic psychoactive drug. MDEA is a substituted amphetamine and a substituted methylenedioxyphenethylamine. MDEA acts as a serotonin, norepinephrine, and dopamine releasing agent and reuptake inhibitor. Possession of MDEA is illegal in most countries. Some limited exceptions exist for scientific and medical research. MDEA currently has no accepted